Omega-3 Eicosapentaenoic Acid Decreases CD133 Colon Cancer Stem-Like Cell Marker Expression While Increasing Sensitivity to Chemotherapy

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  De Carlo, Flavia ^a   Witte, Theodore R ^a   Hardman, W Elaine ^a   Claudio, Pier Paolo ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CELL MARKER; CYTOKERATIN 20; FLUOROURACIL; ICOSAPENTAENOIC ACID; MESSENGER RNA; MUCIN 2; OMEGA 3 FATTY ACID; OXALIPLATIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL COUNT; CELL DIFFERENTIATION; CELL METABOLISM; CELL POPULATION; CHEMOSENSITIVITY; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIPID MEMBRANE; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; EICOSAPENTAENOIC ACID; FLUOROURACIL; GLYCOPROTEINS; HUMANS; NEOPLASTIC STEM CELLS; ORGANOPLATINUM COMPOUNDS; PEPTIDES;

EID: 84880498729     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069760     Document Type: Article

References (69)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M, (2001) Cancer statistics, 2001. CA Cancer J Clin 51: 15-36.
2. Saunders M, Iveson T, (2006) Management of advanced colorectal cancer: state of the art. Br J Cancer 95: 131-138.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
4. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
5. Presnell SC, Petersen B, Heidaran M, (2002) Stem cells in adult tissues. Semin Cell Dev Biol 13: 369-376.
6. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
7. O'Brien CA, Pollett A, Gallinger S, Dick JE, (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
8. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, et al. (2008) Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 15: 638-648.
9. Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, et al. (2010) Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 102: 1265-1275.
10. Li CY, Li BX, Liang Y, Peng RQ, Ding Y, et al. (2009) Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med 7: 56.
11. Horst D, Kriegl L, Engel J, Kirchner T, Jung A, (2009) Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest 27: 844-850.
12. Caygill CP, Charlett A, Hill MJ, (1996) Fat, fish, fish oil and cancer. Br J Cancer 74: 159-164.
13. Caygill CP, Hill MJ, (1995) Fish, n-3 fatty acids and human colorectal and breast cancer mortality. Eur J Cancer Prev 4: 329-332.
14. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, et al. (2004) n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and-2 and HIF-1alpha induction pathway. Carcinogenesis 25: 2303-2310.
15. Calviello G, Di Nicuolo F, Serini S, Piccioni E, Boninsegna A, et al. (2005) Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil. Cancer Chemother Pharmacol 55: 12-20.
16. Narayanan BA, Narayanan NK, Desai D, Pittman B, Reddy BS, (2004) Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Carcinogenesis 25: 2443-2449.
17. Roynette CE, Calder PC, Dupertuis YM, Pichard C, (2004) n-3 polyunsaturated fatty acids and colon cancer prevention. Clin Nutr 23: 139-151.
18. Germain E, Lavandier F, Chajes V, Schubnel V, Bonnet P, et al. (1999) Dietary n-3 polyunsaturated fatty acids and oxidants increase rat mammary tumor sensitivity to epirubicin without change in cardiac toxicity. Lipids 34Suppl: S203.
19. Rudra PK, Krokan HE, (2001) Cell-specific enhancement of doxorubicin toxicity in human tumour cells by docosahexaenoic acid. Anticancer Res 21: 29-38.
20. Burns CP, North JA, (1986) Adriamycin transport and sensitivity in fatty acid-modified leukemia cells. Biochim Biophys Acta 888: 10-17.
21. Hardman WE, Avula CP, Fernandes G, Cameron IL, (2001) Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 7: 2041-2049.
22. Kimura Y, Takaku T, Nakajima S, Okuda H, (2001) Effects of carp and tuna oils on 5-fluorouracil-induced antitumor activity and side effects in sarcoma 180-bearing mice. Lipids 36: 353-359.
23. Cha MC, Meckling KA, Stewart C, (2002) Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice. Nutr Cancer 44: 176-181.
24. Varney ME, Hardman WE, Sollars VE, (2009) Omega 3 fatty acids reduce myeloid progenitor cell frequency in the bone marrow of mice and promote progenitor cell differentiation. Lipids Health Dis 8: 9.
25. Liu YE, Pu W, Wang J, Kang JX, Shi YE, (2007) Activation of Stat5 and induction of a pregnancy-like mammary gland differentiation by eicosapentaenoic and docosapentaenoic omega-3 fatty acids. FEBS J 274: 3351-3362.
26. Serini S, Fasano E, Piccioni E, Monego G, Cittadini AR, et al. (2012) DHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and beta-catenin nuclear translocation. Carcinogenesis 33: 164-173.
27. Wang M, Liu YE, Ni J, Aygun B, Goldberg ID, et al. (2000) Induction of mammary differentiation by mammary-derived growth inhibitor-related gene that interacts with an omega-3 fatty acid on growth inhibition of breast cancer cells. Cancer Res 60: 6482-6487.
28. Hanada H, Morikawa K, Hirota K, Nonaka M, Umehara Y, (2011) Induction of apoptosis and lipogenesis in human preadipocyte cell line by n-3 PUFAs. Cell Biol Int 35: 51-59.
29. Calviello G, Palozza P, Maggiano N, Piccioni E, Franceschelli P, et al. (1999) Cell proliferation, differentiation, and apoptosis are modified by n-3 polyunsaturated fatty acids in normal colonic mucosa. Lipids 34: 599-604.
30. Fahrmann JF, Ballester OF, Ballester G, Witte TR, Salazar AJ, et al. (2013) Inhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty Acids. Cancer Invest 31: 29-43.
31. Hardman WE, Ion G, (2008) Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer 60: 666-674.
32. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
33. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
34. Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA, (2003) Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 52: 1442-1447.
35. Chen ZM, Wang HL, (2004) Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol 28: 1352-1359.
36. Cross HS, Bajna E, Bises G, Genser D, Kallay E, et al. (1996) Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res 16: 2333-2337.
37. Wildi S, Kleeff J, Maruyama H, Maurer CA, Friess H, et al. (1999) Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer. Clin Cancer Res 5: 2840-2847.
38. Chang SK, Dohrman AF, Basbaum CB, Ho SB, Tsuda T, et al. (1994) Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 107: 28-36.
39. Weiss AA, Babyatsky MW, Ogata S, Chen A, Itzkowitz SH, (1996) Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem 44: 1161-1166.
40. Sylvester PA, Myerscough N, Warren BF, Carlstedt I, Corfield AP, et al. (2001) Differential expression of the chromosome 11 mucin genes in colorectal cancer. J Pathol 195: 327-335.
41. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, et al. (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402.
42. Tedelind S, Westberg F, Kjerrulf M, Vidal A, (2007) Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World journal of gastroenterology: WJG. 13: 2826-2832.
43. Finstad HS, Kolset SO, Holme JA, Wiger R, Farrants AK, et al. (1994) Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells. Blood 84: 3799-3809.
44. Nilsson A, Farrants AK, Nesland JM, Finstad HS, Pedersen JI, (1995) Potentiating effects of clofibric acid on the differentiation of HL-60 human promyelocytic leukemia cells induced by retinoids. European journal of cell biology 67: 379-385.
45. Nikolakopoulou Z, Shaikh MH, Dehlawi H, Michael-Titus AT, Parkinson EK, (2013) The induction of apoptosis in pre-malignant keratinocytes by omega-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is inhibited by albumin. Toxicology letters 218: 150-158.
46. Sato SB, Park J, Kawamoto J, Sato S, Kurihara T, (2013) Inhibition of constitutive Akt (PKB) phosphorylation by docosahexaenoic acid in the human breast cancer cell line MDA-MB-453. Biochimica et biophysica acta 1831: 306-313.
47. Kisos H, Pukass K, Ben-Hur T, Richter-Landsberg C, Sharon R, (2012) Increased neuronal alpha-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling alpha-synucleinopathies. PloS one 7: e46817.
48. Degen C, Ecker J, Piegholdt S, Liebisch G, Schmitz G, et al. (2011) Metabolic and growth inhibitory effects of conjugated fatty acids in the cell line HT-29 with special regard to the conversion of t11,t13-CLA. Biochimica et biophysica acta 1811: 1070-1080.
49. Kuan CY, Walker TH, Luo PG, Chen CF, (2011) Long-chain polyunsaturated fatty acids promote paclitaxel cytotoxicity via inhibition of the MDR1 gene in the human colon cancer Caco-2 cell line. Journal of the American College of Nutrition 30: 265-273.
50. Bianchini F, Giannoni E, Serni S, Chiarugi P, Calorini L, (2012) 22: 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis. The British journal of nutrition 108: 2129-2137.
51. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, et al. (2008) CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15: 2927-2933.
52. Chen KL, Pan F, Jiang H, Chen JF, Pei L, et al. (2011) Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells. Clin Exp Metastasis 28: 751-763.
53. Harvey KA, Walker CL, Xu Z, Whitley P, Pavlina TM, et al. (2010) Oleic acid inhibits stearic acid-induced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cells. J Lipid Res 51: 3470-3480.
54. Hardman WE, Moyer MP, Cameron IL, (2002) Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice. Br J Cancer 86: 983-988.
55. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, et al. (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343-2351.
56. Di Francesco AM, Ruggiero A, Riccardi R, (2002) Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Sci 59: 1914-1927.
57. Moore N, Lyle S (2011) Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol 2011.
58. Moitra K, Lou H, Dean M, (2011) Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development. Clin Pharmacol Ther 89: 491-502.
59. Frosina G, (2010) The bright and the dark sides of DNA repair in stem cells. J Biomed Biotechnol 2010: 845396.
60. Judson I, Kelland LR (2000) New developments and approaches in the platinum arena. Drugs 59 Suppl 4: 29-36; discussion 37-28.
61. Giaccone G (2000) Clinical perspectives on platinum resistance. Drugs 59 Suppl 4: 917; discussion 37-18.
62. Siddik ZH, (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279.
63. Mishima M, Samimi G, Kondo A, Lin X, Howell SB, (2002) The cellular pharmacology of oxaliplatin resistance. Eur J Cancer 38: 1405-1412.
64. Wang D, Lippard SJ, (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307-320.
65. Liu Z, Qiu M, Tang QL, Liu M, Lang N, et al. (2010) Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines. Chin J Cancer 29: 661-667.
66. Kuan CY, Walker TH, Luo PG, Chen CF, (2011) Long-chain polyunsaturated fatty acids promote paclitaxel cytotoxicity via inhibition of the MDR1 gene in the human colon cancer Caco-2 cell line. J Am Coll Nutr 30: 265-273.
67. Deng YH, Pu XX, Huang MJ, Xiao J, Zhou JM, et al. (2010) 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells. Chin J Cancer 29: 810-815.
68. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
69. Pham PV, Phan NL, Nguyen NT, Truong NH, Duong TT, et al. (2011) Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy. J Transl Med 9: 209.